Sherif S. Morgan, Ph.D.
Affiliations: | 2009 | Cancer Biology | University of Arizona, Tucson, AZ |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Sherif Morgan"Mean distance: (not calculated yet)
Parents
Sign in to add mentorEmmanuelle J. Meuillet | grad student | 2009 | University of Arizona | |
(The bile acid, deoxycholic acid, modulates IGF-IR function in colon cancer cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Morgan SS, Cranmer LD. (2014) Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells. Bmc Research Notes. 7: 812 |
Morgan SS, Feldman R, Cranmer LD. (2014) Identification of putative molecular targets in Merkel cell carcinoma. Journal of Clinical Oncology. 32 |
Cranmer LD, Morgan SS, Feldman R, et al. (2014) Biomarker patterns of metastatic melanoma with implications for therapy. Journal of Clinical Oncology. 32 |
Cruz-Muñoz W, Jaramillo ML, Man S, et al. (2012) Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma. Cancer Research. 72: 4909-19 |
Morgan SS, Cranmer LD. (2012) Abstract 2820: Vorinostat abrogates ridaforolimus-induced activation of Akt in synovial sarcoma cells: A possible rationale for their synergism Cancer Research. 72: 2820-2820 |
Meuillet EJ, Mash EA, Olsen E, et al. (2011) Abstract A242: A novel AKT inhibitor, PH427, prevents UVB-induced signaling in human squamous skin carcinomas. Molecular Cancer Therapeutics. 10 |
Cranmer LD, Engelhardt C, Morgan SS. (2010) Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. The Oncologist. 15: 1320-8 |
Cranmer LD, Jeter JM, Morgan SS, et al. (2010) Whole-brain radiation therapy in melanoma: an open question. The Lancet. Oncology. 11: 13; author reply 13- |